News

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.
FRIDAY, June 20, 2025 (HealthDay News) — A new shot to prevent HIV infection has just been approved — and it only needs to be ...
A twice-yearly injection of lenacapavir would offer near-complete protection against the virus, clinical date indicate. More pharmaceutical news is about Dupixent, GLP-1 results, and more.
FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect ...
Amy Grant joined artists Matt Maher, Brandon Health, Charlie Peacock and Steve Taylor at a performance at Otter Creek Church ...
The Wistar Institute has launched its HIV Cure and Viral Diseases Center with new lab space on Market Street and a plan to ...
The FDA approved Yeztugo (lenacapavir), a twice-yearly injection that prevents HIV with up to 99.9% effectiveness, showing ...
Greek City Times Scientists Delete HIV from Human Cells in World-First Breakthrough Scientists have successfully deleted the ...
The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent ...
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...
Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.
A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...